The Anti-Proliferative Activity of Coordination Compound-Based ZnO Nanoparticles as a Promising Agent Against Triple Negative Breast Cancer Cells
Hana Stepankova,1,2 Marcin Swiatkowski,3 Rafal Kruszynski,3 Pavel Svec,1 Hana Michalkova,1 Vendula Smolikova,1,2 Andrea Ridoskova,1,4 Zbynek Splichal,1,2 Petr Michalek,1,2 Lukas Richtera,1,2 Pavel Kopel,5 Vojtech Adam,1,2 Zbynek Heger,1,2 Simona Rex1,2 1Department of Chemistry and Biochemistry, Mend...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/3054f143758141189808b09a465c48b1 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:3054f143758141189808b09a465c48b1 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:3054f143758141189808b09a465c48b12021-12-02T16:11:30ZThe Anti-Proliferative Activity of Coordination Compound-Based ZnO Nanoparticles as a Promising Agent Against Triple Negative Breast Cancer Cells1178-2013https://doaj.org/article/3054f143758141189808b09a465c48b12021-07-01T00:00:00Zhttps://www.dovepress.com/the-anti-proliferative-activity-of-coordination-compound-based-zno-nan-peer-reviewed-fulltext-article-IJNhttps://doaj.org/toc/1178-2013Hana Stepankova,1,2 Marcin Swiatkowski,3 Rafal Kruszynski,3 Pavel Svec,1 Hana Michalkova,1 Vendula Smolikova,1,2 Andrea Ridoskova,1,4 Zbynek Splichal,1,2 Petr Michalek,1,2 Lukas Richtera,1,2 Pavel Kopel,5 Vojtech Adam,1,2 Zbynek Heger,1,2 Simona Rex1,2 1Department of Chemistry and Biochemistry, Mendel University in Brno, Brno, Czechia; 2Central European Institute of Technology, Brno University of Technology, Brno, Czechia; 3Institute of General and Ecological Chemistry, Lodz University of Technology, Lodz, Poland; 4Central European Institute of Technology, Mendel University in Brno, Brno, Czechia; 5Department of Inorganic Chemistry, Faculty of Science, Palacky University, Olomouc, CzechiaCorrespondence: Simona RexDepartment of Chemistry and Biochemistry, Mendel University in Brno, Brno, CzechiaTel +420-5-4513-3350Fax +425-5-4521-2044Email simona.rex@mendelu.czPurpose: The present study deals with the in vitro evaluation of the potential use of coordination compound-based zinc oxide (ZnO) nanoparticles (NPs) for the treatment of triple negative breast cancer cells (TNBrCa). As BrCa is one of the most prevalent cancer types and TNBrCa treatment is difficult due to poor prognosis and a high metastasis rate, finding a more reliable treatment option should be of the utmost interest.Methods: Prepared by reacting zinc carboxylates (formate, acetate, propionate, butyrate, isobutyrate, valerate) and hexamethylenetetramine, 4 distinct coordination compounds were further subjected to two modes of conversion into ZnO NPs – ultrasonication with oleic acid or heating of pure precursors in an air atmosphere. After detailed characterization, the resulting ZnO NPs were subjected to in vitro testing of cytotoxicity toward TNBrCa and normal breast epithelial cells. Further, their biocompatibility was evaluated.Results: The resulting ZnO NPs provide distinct morphological features, size, biocompatibility, and selective cytotoxicity toward TNBrCa cells. They internalize into two types of TNBrCa cells and imbalance their redox homeostasis, influencing their metabolism, morphology, and ultimately leading to their death via apoptosis or necrosis.Conclusion: The crucial properties of ZnO NPs seem to be their morphology, size, and zinc content. The ZnO NPs with the most preferential values of all three properties show great promise for a future potential use in the therapy of TNBrCa.Keywords: carboxylate, hexamethylenetetramine, nanoparticles, redox homeostasis imbalance, triple negative breast cancer, zinc oxide coordination compoundsStepankova HSwiatkowski MKruszynski RSvec PMichalkova HSmolikova VRidoskova ASplichal ZMichalek PRichtera LKopel PAdam VHeger ZRex SDove Medical Pressarticlecarboxylatehexamethylenetetraminenanoparticlesredox homeostasis imbalancetriple negative breast cancerzinc oxide coordination compoundsMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 16, Pp 4431-4449 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
carboxylate hexamethylenetetramine nanoparticles redox homeostasis imbalance triple negative breast cancer zinc oxide coordination compounds Medicine (General) R5-920 |
| spellingShingle |
carboxylate hexamethylenetetramine nanoparticles redox homeostasis imbalance triple negative breast cancer zinc oxide coordination compounds Medicine (General) R5-920 Stepankova H Swiatkowski M Kruszynski R Svec P Michalkova H Smolikova V Ridoskova A Splichal Z Michalek P Richtera L Kopel P Adam V Heger Z Rex S The Anti-Proliferative Activity of Coordination Compound-Based ZnO Nanoparticles as a Promising Agent Against Triple Negative Breast Cancer Cells |
| description |
Hana Stepankova,1,2 Marcin Swiatkowski,3 Rafal Kruszynski,3 Pavel Svec,1 Hana Michalkova,1 Vendula Smolikova,1,2 Andrea Ridoskova,1,4 Zbynek Splichal,1,2 Petr Michalek,1,2 Lukas Richtera,1,2 Pavel Kopel,5 Vojtech Adam,1,2 Zbynek Heger,1,2 Simona Rex1,2 1Department of Chemistry and Biochemistry, Mendel University in Brno, Brno, Czechia; 2Central European Institute of Technology, Brno University of Technology, Brno, Czechia; 3Institute of General and Ecological Chemistry, Lodz University of Technology, Lodz, Poland; 4Central European Institute of Technology, Mendel University in Brno, Brno, Czechia; 5Department of Inorganic Chemistry, Faculty of Science, Palacky University, Olomouc, CzechiaCorrespondence: Simona RexDepartment of Chemistry and Biochemistry, Mendel University in Brno, Brno, CzechiaTel +420-5-4513-3350Fax +425-5-4521-2044Email simona.rex@mendelu.czPurpose: The present study deals with the in vitro evaluation of the potential use of coordination compound-based zinc oxide (ZnO) nanoparticles (NPs) for the treatment of triple negative breast cancer cells (TNBrCa). As BrCa is one of the most prevalent cancer types and TNBrCa treatment is difficult due to poor prognosis and a high metastasis rate, finding a more reliable treatment option should be of the utmost interest.Methods: Prepared by reacting zinc carboxylates (formate, acetate, propionate, butyrate, isobutyrate, valerate) and hexamethylenetetramine, 4 distinct coordination compounds were further subjected to two modes of conversion into ZnO NPs – ultrasonication with oleic acid or heating of pure precursors in an air atmosphere. After detailed characterization, the resulting ZnO NPs were subjected to in vitro testing of cytotoxicity toward TNBrCa and normal breast epithelial cells. Further, their biocompatibility was evaluated.Results: The resulting ZnO NPs provide distinct morphological features, size, biocompatibility, and selective cytotoxicity toward TNBrCa cells. They internalize into two types of TNBrCa cells and imbalance their redox homeostasis, influencing their metabolism, morphology, and ultimately leading to their death via apoptosis or necrosis.Conclusion: The crucial properties of ZnO NPs seem to be their morphology, size, and zinc content. The ZnO NPs with the most preferential values of all three properties show great promise for a future potential use in the therapy of TNBrCa.Keywords: carboxylate, hexamethylenetetramine, nanoparticles, redox homeostasis imbalance, triple negative breast cancer, zinc oxide coordination compounds |
| format |
article |
| author |
Stepankova H Swiatkowski M Kruszynski R Svec P Michalkova H Smolikova V Ridoskova A Splichal Z Michalek P Richtera L Kopel P Adam V Heger Z Rex S |
| author_facet |
Stepankova H Swiatkowski M Kruszynski R Svec P Michalkova H Smolikova V Ridoskova A Splichal Z Michalek P Richtera L Kopel P Adam V Heger Z Rex S |
| author_sort |
Stepankova H |
| title |
The Anti-Proliferative Activity of Coordination Compound-Based ZnO Nanoparticles as a Promising Agent Against Triple Negative Breast Cancer Cells |
| title_short |
The Anti-Proliferative Activity of Coordination Compound-Based ZnO Nanoparticles as a Promising Agent Against Triple Negative Breast Cancer Cells |
| title_full |
The Anti-Proliferative Activity of Coordination Compound-Based ZnO Nanoparticles as a Promising Agent Against Triple Negative Breast Cancer Cells |
| title_fullStr |
The Anti-Proliferative Activity of Coordination Compound-Based ZnO Nanoparticles as a Promising Agent Against Triple Negative Breast Cancer Cells |
| title_full_unstemmed |
The Anti-Proliferative Activity of Coordination Compound-Based ZnO Nanoparticles as a Promising Agent Against Triple Negative Breast Cancer Cells |
| title_sort |
anti-proliferative activity of coordination compound-based zno nanoparticles as a promising agent against triple negative breast cancer cells |
| publisher |
Dove Medical Press |
| publishDate |
2021 |
| url |
https://doaj.org/article/3054f143758141189808b09a465c48b1 |
| work_keys_str_mv |
AT stepankovah theantiproliferativeactivityofcoordinationcompoundbasedznonanoparticlesasapromisingagentagainsttriplenegativebreastcancercells AT swiatkowskim theantiproliferativeactivityofcoordinationcompoundbasedznonanoparticlesasapromisingagentagainsttriplenegativebreastcancercells AT kruszynskir theantiproliferativeactivityofcoordinationcompoundbasedznonanoparticlesasapromisingagentagainsttriplenegativebreastcancercells AT svecp theantiproliferativeactivityofcoordinationcompoundbasedznonanoparticlesasapromisingagentagainsttriplenegativebreastcancercells AT michalkovah theantiproliferativeactivityofcoordinationcompoundbasedznonanoparticlesasapromisingagentagainsttriplenegativebreastcancercells AT smolikovav theantiproliferativeactivityofcoordinationcompoundbasedznonanoparticlesasapromisingagentagainsttriplenegativebreastcancercells AT ridoskovaa theantiproliferativeactivityofcoordinationcompoundbasedznonanoparticlesasapromisingagentagainsttriplenegativebreastcancercells AT splichalz theantiproliferativeactivityofcoordinationcompoundbasedznonanoparticlesasapromisingagentagainsttriplenegativebreastcancercells AT michalekp theantiproliferativeactivityofcoordinationcompoundbasedznonanoparticlesasapromisingagentagainsttriplenegativebreastcancercells AT richteral theantiproliferativeactivityofcoordinationcompoundbasedznonanoparticlesasapromisingagentagainsttriplenegativebreastcancercells AT kopelp theantiproliferativeactivityofcoordinationcompoundbasedznonanoparticlesasapromisingagentagainsttriplenegativebreastcancercells AT adamv theantiproliferativeactivityofcoordinationcompoundbasedznonanoparticlesasapromisingagentagainsttriplenegativebreastcancercells AT hegerz theantiproliferativeactivityofcoordinationcompoundbasedznonanoparticlesasapromisingagentagainsttriplenegativebreastcancercells AT rexs theantiproliferativeactivityofcoordinationcompoundbasedznonanoparticlesasapromisingagentagainsttriplenegativebreastcancercells AT stepankovah antiproliferativeactivityofcoordinationcompoundbasedznonanoparticlesasapromisingagentagainsttriplenegativebreastcancercells AT swiatkowskim antiproliferativeactivityofcoordinationcompoundbasedznonanoparticlesasapromisingagentagainsttriplenegativebreastcancercells AT kruszynskir antiproliferativeactivityofcoordinationcompoundbasedznonanoparticlesasapromisingagentagainsttriplenegativebreastcancercells AT svecp antiproliferativeactivityofcoordinationcompoundbasedznonanoparticlesasapromisingagentagainsttriplenegativebreastcancercells AT michalkovah antiproliferativeactivityofcoordinationcompoundbasedznonanoparticlesasapromisingagentagainsttriplenegativebreastcancercells AT smolikovav antiproliferativeactivityofcoordinationcompoundbasedznonanoparticlesasapromisingagentagainsttriplenegativebreastcancercells AT ridoskovaa antiproliferativeactivityofcoordinationcompoundbasedznonanoparticlesasapromisingagentagainsttriplenegativebreastcancercells AT splichalz antiproliferativeactivityofcoordinationcompoundbasedznonanoparticlesasapromisingagentagainsttriplenegativebreastcancercells AT michalekp antiproliferativeactivityofcoordinationcompoundbasedznonanoparticlesasapromisingagentagainsttriplenegativebreastcancercells AT richteral antiproliferativeactivityofcoordinationcompoundbasedznonanoparticlesasapromisingagentagainsttriplenegativebreastcancercells AT kopelp antiproliferativeactivityofcoordinationcompoundbasedznonanoparticlesasapromisingagentagainsttriplenegativebreastcancercells AT adamv antiproliferativeactivityofcoordinationcompoundbasedznonanoparticlesasapromisingagentagainsttriplenegativebreastcancercells AT hegerz antiproliferativeactivityofcoordinationcompoundbasedznonanoparticlesasapromisingagentagainsttriplenegativebreastcancercells AT rexs antiproliferativeactivityofcoordinationcompoundbasedznonanoparticlesasapromisingagentagainsttriplenegativebreastcancercells |
| _version_ |
1718384402255314944 |